MET and lung adenocarcinoma: S49076 could exert its cytotoxic action at low doses on Met-dependent cells, GTL16 and U87-MG, via MET inhibition, whereas it restrained the growth of MET-independent lung adenocarcinoma cells H441, H460, and A549 at higher but clinically relevant doses by targeting AURKB.